395 related articles for article (PubMed ID: 19891206)
1. A review of the effect of pharmaceutical firm drug announcements on stock option pricing.
Younis MM; Younies H; Kisa A; Hartmann M; Hussain AA; Al-Amro A
J Health Care Finance; 2009; 35(3):35-43. PubMed ID: 19891206
[TBL] [Abstract][Full Text] [Related]
2. Company stock prices before and after public announcements related to oncology drugs.
Rothenstein JM; Tomlinson G; Tannock IF; Detsky AS
J Natl Cancer Inst; 2011 Oct; 103(20):1507-12. PubMed ID: 21949081
[TBL] [Abstract][Full Text] [Related]
3. Biotechnology stock prices before public announcements: evidence of insider trading?
Overgaard CB; van den Broek RA; Kim JH; Detsky AS
J Investig Med; 2000 Mar; 48(2):118-24. PubMed ID: 10736971
[TBL] [Abstract][Full Text] [Related]
4. Security market reaction to FDA fast track designations.
Anderson CW; Zhang Y
J Health Care Finance; 2010; 37(2):27-48. PubMed ID: 21294437
[TBL] [Abstract][Full Text] [Related]
5. For the last time: stock options are an expense.
Bodie Z; Kaplan RS; Merton RC
Harv Bus Rev; 2003 Mar; 81(3):62-71, 140. PubMed ID: 12632805
[TBL] [Abstract][Full Text] [Related]
6. The economics of priority review vouchers.
Dimitri N
Drug Discov Today; 2010 Nov; 15(21-22):887-91. PubMed ID: 20732445
[TBL] [Abstract][Full Text] [Related]
7. Strategies and impacts of new drug introduction: hemophilia treatment.
Guirguis HS; Rogoff EG
J Health Care Finance; 2004; 31(1):1-12. PubMed ID: 15816224
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics--an investment worth making?
Christoffersen RE
Nat Biotechnol; 2006 Dec; 24(12):1512-4. PubMed ID: 17160052
[TBL] [Abstract][Full Text] [Related]
9. Expensing stock options: a fair-value approach.
Kaplan RS; Palepu KG
Harv Bus Rev; 2003 Dec; 81(12):105-8, 126. PubMed ID: 14712549
[TBL] [Abstract][Full Text] [Related]
10. Microcap pharmaceutical firms: linking drug pipelines to market value.
Beach R
J Health Care Finance; 2012; 39(2):82-92. PubMed ID: 23971143
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical companies: safe stock market investments.
Prescrire Int; 2012 Oct; 21(131):251. PubMed ID: 23185855
[No Abstract] [Full Text] [Related]
12. The strategic interaction between firms and formulary committees: effects on the prices of new drugs.
García-Alonso MD; García-Mariñoso B
J Health Econ; 2008 Mar; 27(2):377-404. PubMed ID: 18276026
[TBL] [Abstract][Full Text] [Related]
13. Drug development costs when financial risk is measured using the Fama-French three-factor model.
Vernon JA; Golec JH; Dimasi JA
Health Econ; 2010 Aug; 19(8):1002-5. PubMed ID: 19655335
[TBL] [Abstract][Full Text] [Related]
14. Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companies.
Hwang TJ
PLoS One; 2013; 8(8):e71966. PubMed ID: 23951273
[TBL] [Abstract][Full Text] [Related]
15. FDA withholds approval of anti-infection drug; manufacturer's stock price plunges.
Wagner M
Mod Healthc; 1992 Apr; 22(16):6. PubMed ID: 10117563
[No Abstract] [Full Text] [Related]
16. The risk we bear: the effects of review speed and industry user fees on new drug safety.
Olson MK
J Health Econ; 2008 Mar; 27(2):175-200. PubMed ID: 18207263
[TBL] [Abstract][Full Text] [Related]
17. Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.
Augurzky B; Göhlmann S; Gress S; Wasem J
Health Econ; 2009 Apr; 18(4):421-36. PubMed ID: 18677725
[TBL] [Abstract][Full Text] [Related]
18. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments.
Han E; Kim TH; Jeung MJ; Lee EK
Clin Ther; 2013 Jul; 35(7):941-9. PubMed ID: 23806327
[TBL] [Abstract][Full Text] [Related]
19. Real options reasoning in healthcare: an integrative approach and synopsis.
Williams DR; Hammes PH
J Healthc Manag; 2007; 52(3):170-86; discussion 187. PubMed ID: 17552354
[TBL] [Abstract][Full Text] [Related]
20. Great company, bad stock.
Jacobs T
Nat Biotechnol; 2005 Feb; 23(2):173. PubMed ID: 15696142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
